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For the first set of Troponin, the study showed that 
both methodologies, POC Troponin and automated 
Laboratory Troponin, can be trusted to perform 
equally. They both showed low sensitivity and high 
specificity in the diagnosing heart events. This  
demonstration of high-specificity cardiac Troponin 
testing true value will continue to help us in the early 
diagnosis of a cardiac event thus facilitating the 
speedy treatment of all true cardiac events thereby 
improving the patient’s recovery and reduction of 
mortality. 
 
The low sensitivity is probably due in part to the fact 
that the measures were only the first Troponin  
measurements for a patient.  It is recommended to 
have serial measurements in patients suspected of 
having a heart event. 
 
Nursing care continues to be validated by research 
based evidence. It is noteworthy to see that the results 
of this research has shown that early detection of  
increased Troponin level by a highly specific analysis 
on patients presented in the ED with chest pain has a 
valuable place in the early treatment of chest pain 
thus preventing mortality and decreasing morbidity in 
patients with cardiac events. 
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The exact value of the laboratory  and POC Troponin 
are not expected to be the same. They are different 
methodologies with different calibration. The  
manufacturer’s suggested cut-off values to consider 
elevated Troponin is 0.06 for the laboratory values 
and 0.08 for the POC values.  Using the suggested 
cut-off scores 99 of the 1,567 subjects (6.3%) had an  
elevated laboratory Troponin and 82 of the 1,567  
subjects (5.2%) had an elevated POC Troponin. 
 
 Figure 1 demonstrates  that  the values of the Lab 
 Troponins are systematically higher than the POC 
 Troponin therefore it is not appropriate to compute 
 an intraclass correlation  coefficient (ICC )  
 between to the two values to estimate reliability.  
 Instead we used regression analysis and validity  
 coefficients.   
 Figure 2  shows the pairs of Troponin values fall 
 very close to the regression line between  
 laboratory and POC Troponin. Overall the  
 correlation between the two Troponin results was  
 r = 0.9627 (p < 0.0001).   
 
Depending on the cut-off values for Troponin, the  
sensitivity of the tests for detecting subjects with a  
principal diagnosis of MI varied between 54% and 
64%, the specificity varied between 96% and 98%. 
 
 
Results 
 
Cardiac Troponin is detected in the blood stream 
of patients with  myocardial injury using        
sensitive and specific assays. The importance of 
using a precise assay that can  measure Troponin 
at a very high percentile with a very low  total  
imprecision will facilitate the diagnosis of MI on 
admission in acute coronary syndrome (ACS) 
and other non-STEMIs diagnosis. In this study 
we compared two different Troponin            
methodologies for validity. 
The purpose of this study was to demonstrate that 
there is no significant difference between the 
Emergency Department’s Point of Care (POC) 
Troponin test (i-STAT) and the Automated  
Laboratory Troponin Analyzers. The goal of the 
study was to demonstrate that by using different  
methodologies, the presence or absence of a  
cardiac event will still be detected. 
Purpose 
A secondary analysis of retrospective data for six 
months, June 2012-December 2012, was  
conducted at a community hospital in Miami,  
Florida. The study included 1,567 subjects for 
whom Troponin tests were done using both  
methodologies on blood samples collected at the 
same draw or within 15 minutes of each other (the 
first 2 Troponin values for each other). 
Methods of Implementation  
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Figure 2: 
Regression analysis to measure validity of the lab and POC  
Troponin methodologies. 
Figure 1: 
Intraclass Correlation Coefficient for Troponin values for the 
two methodologies. 
